News
Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...
Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.
Charlottesville biotech support helps startups like Luminoah and Rivus grow, with the Manning Institute and CvilleBioHub leading the way ...
3d
MoneyWeek on MSNCash in on the biotech boom with three promising European picksAilsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...
Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees.
(KRON) — The future of one biotech company on the Peninsula is drastically changing. Unity Biotechnology is laying off its entire workforce, the company announced Monday in a press release.
Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies insisted the sensitive genetic data provided to 23andMe by 15 million ...
Genetic data was on the auction block, and a U.S. biotech company ponied up the cash. New York-based Regeneron Pharmaceuticals announced on Monday that it has purchased DNA testing company 23andMe ...
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and therefore flagged by the Imperva network. Imperva displays this page for you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results